Production & Manufacturing
News
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.
This investment reflects Biovian’s commitment to meeting the growing demand for...
News
New PAT – Based Strategy Stops Membrane Fouling In SP – TFF
A recent article published in the Journal of Membrane Science presents a new approach for implementing a robust single-pass tangential flow filtration (SP-TFF) operation in biomanufacturing. The authors introduce a process analytical technology (PAT)-based strategy that integrates and continuously...
BioPharma
Cell And Gene Therapy CDMO Services Market Is On The Rise
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which was valued at USD 5,193.7 million in 2022, is expected to grow at a CAGR of 17.5% during the forecast period from 2023 to...
BioPharma
Lack of Experience Hinders CDMOs In Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy manufacturing for Phase III trials and commercialization. While physical capacity has been blamed, the...
Drug Research
WHO & Republic of Korea Tie-Up For Biomanufacturing Training
The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a worldwide training hub when it comes to biomanufacturing. The worldwide training centre will go on...
BioPharma
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
The cell & gene therapy (CGT) CDMO...
News
UNDBIO to Build $100M Insulin Manufacturing Facility in West Virginia
UNDBIO, a South Korean pharmaceutical company focused on diabetic care, will spend $100 million to build an insulin manufacturing facility in West Virginia.
The project is expected to create 200 new jobs in the first three years, according to an April...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read